FGF21, not GCN2, influences bone morphology due to dietary protein restrictions

Background: Dietary protein restriction is emerging as an alternative approach to treat obesity and glucose intolerance because it markedly increases plasma fibroblast growth factor 21 (FGF21) concentrations. Similarly, dietary restriction of methionine is known to mimic metabolic effects of energy...

Full description

Bibliographic Details
Main Authors: Margaret A. McNulty, Brad A. Goupil, Diana C. Albarado, Teresa Castaño-Martinez, Thomas H. Ambrosi, Spela Puh, Tim J. Schulz, Annette Schürmann, Christopher D. Morrison, Thomas Laeger
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Bone Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352187219300476